Ignite Creation Date:
2025-12-25 @ 4:19 AM
Ignite Modification Date:
2025-12-31 @ 6:55 PM
Study NCT ID:
NCT05951920
Status:
UNKNOWN
Last Update Posted:
2023-07-21
First Post:
2023-07-06
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Lymph Node Aspiration to Decipher the Immune Response of Beta-variant Recombinant Protein Booster Vaccine (VidPrevtyn Beta, Sanofi) Compared to a Bivalent mRNA Vaccine (Comirnaty Original/Omicron BA.4-5, BioNTech-Pfizer) in Adults Previously Vaccinated With at Least 3 Doses of COVID-19 mRNA Vaccine.
Sponsor:
Assistance Publique - Hôpitaux de Paris
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-07-05
Start Date Type:
ACTUAL
Primary Completion Date:
2023-07-22
Primary Completion Date Type:
ESTIMATED
Completion Date:
2023-09
Completion Date Type:
ESTIMATED
First Submit Date:
2023-07-06
First Submit QC Date:
None
Study First Post Date:
2023-07-19
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-07-19
Last Update Post Date:
2023-07-21
Last Update Post Date Type:
ACTUAL